+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Denmark - Healthcare, Regulatory and Reimbursement Landscape

  • PDF Icon

    Report

  • 157 Pages
  • December 2020
  • Region: Denmark
  • GlobalData
  • ID: 4483550
Summary

The publisher, the industry analysis specialist, has released its latest report, “Denmark - Healthcare, Regulatory and Reimbursement Landscape”. The report is an essential source of information on analysis of the healthcare, regulatory and reimbursement landscape in Denmark. It identifies the key trends in the country’s healthcare market and provides insights into its demographic, regulatory and reimbursement landscape, and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by the publisher’s team of industry experts.

The Danish pharmaceutical market, in terms of Danish Krone, increased from DKK20.5B in 2011 to DKK24.7B in 2019 at a Compound Annual Growth Rate (CAGR) of 1.7%. However, in terms of US Dollars, the market decreased slightly from $3.8B in 2011 to $3.7B in 2019 at a negative CAGR of 0.4%. This difference was due to the currency fluctuation between the US Dollar and the Danish Krone. The medical devices market of Denmark was $1.7B in 2015, which increased at a CAGR of 3.3% to reach $1.94B in 2019. The market is expected to grow at a CAGR of 4.4% from $2.01B in 2020 to reach $2.51B in 2025. In March 2018, the government of Denmark introduced a five-year plan to boost the pharmaceutical industry. The plan’s initiatives are spread across six focus areas, such as improving the framework conditions for research and development activities and conducting clinical trials, boosting the Danish Medicines Agency (DKMA), and enhancing access to qualified and skilled labor.

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in Denmark, and includes -
  • An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
  • Profiles and SWOT analyses of the major players in the pharmaceutical market: GlaxoSmithKline, Pfizer, Lundbeck, Novo Nordisk, and Leo Pharma
  • Profiles and SWOT analyses of the major players in the medical device market: Abbott, Alcon, GE Healthcare, Fresenius, and Roche Diagnostics
  • An insightful review of the COVID-19 epidemiology, COVID-19 impact and developments in healthcare market, HealthTech landscape, reimbursement and regulatory landscape, with analysis covering details of the country’s healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices
  • Detailed analysis of the country’s healthcare policy highlights, demographics, healthcare infrastructure and healthcare expenditure
  • An overview of the opportunities for and challenges to growth in the Danish healthcare market

Reasons to Buy

This report will enhance your decision-making capability by allowing you to -
  • Develop business strategies by understanding the trends shaping and driving Denmark’s healthcare market
  • Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments and companies likely to impact Denmark’s healthcare market in the future
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing competitors’ performance
  • Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment and strategic partnership

Table of Contents

1. Table of Contents
1.1 List of Figures
1.2 List of Tables
2. Executive Summary
2.1 Executive Summary - Overview
2.2 Key Highlights - Facts about the Danish Healthcare Market
2.3 Key Highlights: Healthcare Startups in Denmark
2.4 Key Events: Danish Healthcare Industry, 2014-2020
2.5 Key Events: Denmarkian Pharmaceutical Market
2.6 Key Events: M&As, VC & PE Deals, Global Pharmaceutical Market, 2019-2020
2.7 Key Events: Mergers and Acquisitions
2.8 Country Profile, Denmark, 2019
3. Overview of Pharmaceutical Market
3.1 Pharmaceutical Market - Overview
3.2 Pharmaceutical Market - Exports
3.3 Pharmaceutical Market - Imports
3.4 Pharmaceutical Market - Supply Channels, Denmark
3.5 Pharmaceutical Market - Market Segments
3.6 Major Therapeutic Areas, Denmark
3.7 COVID-19 Epidemiology, Denmark
3.8 COVID-19 Impact and Developments, Denmark
3.9 COVID-19 Clinical Trials Landscape, Denmark
3.10 Pharmaceutical Market - Major Players
4. Overview of Medical Devices Market
4.1 Medical Device Market - Overview
4.2 Medical Devices Market - Major Players
5. Pharmaceutical and Medical Devices Market - Drivers and Barriers
5.1 Drivers
5.2 Barriers
6. Deal Analysis
6.1 Deal Analysis: Pharmaceutical Market, Denmark, 2019-2020
6.2 Deal Analysis: Medical Devices Market, Denmark, 2019-2020
7. HealthTech Landscape
7.1 HealthTech Landscape, Denmark
7.2 HealthTech Deals Landscape, Denmark
7.3 Adoption of Technology in Healthcare, Denmark
7.4 Key HealthTech Deals
7.5 Digital Health Regulations, Denmark
7.6 Digital Health: Benefits and Risks, Denmark
8. Market Access
8.1 Overview of Healthcare System, Denmark
8.2 Reimbursement Process, Denmark
8.3 Overview of Insurance Providers, Denmark
8.4 Healthcare Spending and Pharmaceutical Price Index, Denmark
8.5 Pricing Policies, Denmark
8.6 Regulatory Landscape, Denmark
8.6.1 Overview of Regulatory Agencies
8.6.2 Regulatory Landscape, Denmark
8.6.3 Market Authorization for Pharmaceutical Drugs, Denmark
8.6.4 Market Authorization for Medical Devices, Denmark
8.6.5 Intellectual Property Rights, Patent, Denmark
8.6.6 Intellectual Property Rights, Trademark, Denmark
8.6.7 Clinical Trials Regulation, Denmark
8.6.8 Pharmaceutical Clinical Trials Landscape, Denmark
8.6.9 Medical Devices Clinical Trials Landscape, Denmark
8.6.10 Pharmacy License Regulations, Denmark
8.6.11 Online Pharmacy Regulations, Denmark
8.6.12 Pharmaceutical Advertisement Regulations, Denmark
8.6.13 Labeling and Packaging Regulations, Denmark
9. Country Healthcare Landscape
9.1 Healthcare Policy Highlights, Denmark
9.2 Healthcare Facilities, Denmark
9.3 Healthcare Parameters, Denmark
9.4 Life Expectancy and Immunization Rate, Denmark
9.5 Environmental Health, Denmark
9.6 Healthcare Personnel, Denmark
9.7 Disease Burden, Denmark
9.8 Healthcare Expenditure, Denmark
10 Trade Associations, Denmark
11 Conferences and Trade Fairs, Denmark
12 Opportunities and Challenges
13 Appendix
13.1 Research Methodology
13.1.1 Coverage
13.1.2 Secondary Research
13.1.3 Forecasts
13.2 Bibliography
13.3 About the Publisher
13.4 Contact
13.5 Disclaimer
List of Tables
Table 1: Approved Biosimilars, EU, 2019-2020
Table 2: COVID-19 Indicators (Number of cases), Denmark and Global, 2020
Table 3: COVID-19 Healthcare IT Products, Denmark, 2020
Table 4: COVID-19 Ventilators, Denmark, 2020
Table 5: COVID-19 IVD Products, Denmark, 2020
Table 6: Medical Devices Market, Denmark, Major Segments ($M), 2019
Table 7: General Surgery Devices Market, Denmark, Revenue ($M) and Market Share (%) of Major Companies, 2019
Table 8: Wound Care Management Devices Market, Denmark, Revenue ($M) and Market Share (%) of Major Companies, 2019
Table 9: Orthopedic Devices Market, Denmark, Revenue ($M) and Market Share (%) of Major Companies, 2019
Table 10: Healthcare IT Market, Denmark, Revenue ($M) and Market Share (%) of Major Companies, 2019
Table 11: Cardiovascular Devices Market, Denmark, Revenue ($M) and Market Share (%) of Major Companies, 2019
Table 12: Net Assessment and Clock Stop Times, 2017, Denmark
Table 13: Market Authorization Fees, 2020, Denmark
Table 14: Registration fees for medical device manufacturers, 2020, Denmark
Table 15: Registration fees for distributors and importers of medical devices, 2020, Denmark
Table 16: Patent Fees, Denmark, 2020
Table 17: Trademark Fees, Denmark, 2020
Table 18: Clinical Trial Fees, Denmark, 2020
Table 19: Label of a Pharmaceutical Product, Denmark, 2018
Table 20: Label of Radiopharmaceutical Product, Denmark, 2018
Table 21: Labeling of Small Packages, Denmark, 2018
Table 22: Labeling and Packaging Leaflet, Denmark, 2018
Table 23: Trade Fairs, Denmark, 2021
List of Figures
Figure 1: Pharmaceutical Market, Denmark, Revenue ($B and DKK B), 2011-2019
Figure 2: Medical Device Market, Denmark, Revenue ($B), 2015-2020
Figure 3: Healthcare Startups in Denmark, 2020
Figure 4: Country Profile, Denmark, 2019
Figure 5: Pharmaceutical Market, Denmark, Revenue ($B), 2011-2019
Figure 6: Pharmaceutical Market, Denmark, Revenue Forecast ($B), 2020-2025
Figure 7: Danish Growth Strategy for Life Sciences, Denmark, 2018-2023
Figure 8: Pharmaceutical Exports ($M), Denmark, 2010-2019
Figure 9: Top Export Partners, Denmark, 2019
Figure 10: Pharmaceutical Imports ($B), Denmark, 2010-2019
Figure 11: Top Import Partners, Denmark, 2019
Figure 12: Pharmaceutical Supply Channel, Denmark, 2019
Figure 13: Generic Drugs Usage (% share by volume), Denmark, 2010-2019
Figure 14: Generic Drugs Usage (% share by value), Denmark, 2010-2019
Figure 15: OTC Market, Denmark, Major Categories ($M), 2019
Figure 16: OTC Market, Denmark, Revenue ($M), 2013-2020
Figure 17: OTC Drugs Market, Major Distribution Channels ($M), Denmark, 2017
Figure 18: Pharmaceutical Sales by Drug Category ($M), Denmark, 2019
Figure 19: Major Therapeutic Areas by Pharmaceutical Consumption (DDD per 1,000 inhabitants per day), Denmark, 2015-2017
Figure 20: COVID-19 (Number of cases), Denmark, 2020
Figure 21: COVID-19 (Number of deaths), Denmark, 2020
Figure 22: Government Fiscal Measures to Mitigate COVID-19 Impact, Denmark, 2019
Figure 23: Pharmaceutical Clinical Trials Count By Trial Status, Denmark, 2020
Figure 24: Pharmaceutical Clinical Trials Count By Phase, Denmark, 2020
Figure 25: Top Five Pharmaceutical Clinical Trials Sponsors By Count, Denmark, 2020
Figure 26: Pharmaceutical Market, Major Players, 2019
Figure 27: Medical Device Market, Denmark, Revenue ($B), 2015-2020
Figure 28: Medical Device Market, Denmark, Revenue Forecast ($B), 2021-2025
Figure 29: Medical Devices Market, Major Segments (%), Denmark, 2019
Figure 30: General Surgery Devices Market, Denmark, Revenue ($M), 2015-2022
Figure 31: General Surgery Devices Market, Denmark, Market Share of Major Players (%), 2016
Figure 32: Wound Care Management Devices Market, Denmark, Revenue ($M), 2015-2022
Figure 33: Wound Care Management Devices Market, Denmark, Market Share of Major Players (%), 2019
Figure 34: Orthopedic Devices Market, Denmark, Revenue ($B), 2015-2022
Figure 35: Orthopedic Devices Market, Denmark, Market Share of Major Players (%), 2019
Figure 36: Healthcare IT Market, Denmark, Revenue ($M), 2015-2022
Figure 37: Healthcare IT Market, Denmark, Market Share of Major Players (%), 2019
Figure 38: Cardiovascular Devices Market, Denmark, Revenue ($M), 2015-2022
Figure 39: Cardiovascular Devices Market, Denmark, Market Share of Major Players (%), 2019
Figure 40: Diagnostic Market, Denmark, Revenue ($M), 2015-2020
Figure 41: Diagnostic Market, Denmark, Revenue ($M), 2021-2025
Figure 42: Medical Device Market, Denmark, Revenue ($B) of Major Companies, 2019
Figure 43: Deal Value and Deal Count, Pharmaceutical Market, Denmark, 2019-2020
Figure 44: Deal Value and Deal Count Quarterly, Pharmaceutical Market, Denmark, 2019-2020
Figure 45: Deal Value and Deal Count Sub-types, Pharmaceutical Market, Denmark, 2019-2020
Figure 46: Top Therapy Areas by Deal Value, Pharmaceutical Market, Denmark, 2019-2020
Figure 47: Top Therapy Areas by Deal Count, Pharmaceutical Market, Denmark, 2019-2020
Figure 48: M&A Deals by Quarter, Pharmaceutical Market, Denmark, 2019-2020 (by value and by number)
Figure 49: VF Deals by Quarter, Pharmaceutical Market, Denmark, 2019-2020 (by value and by number)
Figure 50: Deal Value and Deal Count, Medical Devices Market, Denmark, 2019-2020
Figure 51: Deal Value and Deal Count, Quarterly, Medical Devices Market, Denmark, 2019-2020
Figure 52: Deal Value and Deal Count Sub-types, Medical Devices Market, Denmark, 2019-2020
Figure 53: Top Equipment Sectors by Deal Value, Medical Devices Market, Denmark, 2019-2020
Figure 54: Top Equipment Sectors by Deal Count, Medical Devices Market, Denmark, 2019-2020
Figure 55: VF Deals by Equipment Sector, Pharmaceutical Market, Denmark, 2019-2020 (by value and by number)
Figure 56: Digital Health Strategy 2018-2022 Focus Areas, Denmark
Figure 57: Deal Value ($M), HealthTech, Denmark, 2019-2020
Figure 58: Deal Count (Number of Deals), HealthTech, Denmark, 2019-2020
Figure 59: Digital Health Legislation Principles, Denmark, 2020
Figure 60: Overview of Health System, Denmark, 2020
Figure 61: Drug Reimbursement (Medicines Reimbursement Board Process), Denmark, 2020
Figure 62: Private Health Insurance (% of total population), Denmark, 2010-2018
Figure 63: Out-of-Pocket Spending (% of health spending), Denmark, 2010-2018
Figure 64: Pharmaceutical Price Index (2015 = 100), Denmark, 2012-2020
Figure 65: Danish Medicines Agency, Organization Chart, 2020
Figure 66: Drug Authorization Procedures, EU, 2019
Figure 67: Centralized Procedure, Denmark, 2019
Figure 68: Decentralized Procedure, Denmark, 2019
Figure 69: Mutual Recognition Procedure, Denmark, 2019
Figure 70: New Drug Approval Process, Denmark, 2019
Figure 71: Conformity Assessment of Class I Medical Devices, EU, 2019
Figure 72: Conformity Assessment of Class IIa Medical Devices, EU, 2019
Figure 73: Conformity Assessment of Class IIb Medical Devices, EU, 2019
Figure 74: Conformity Assessment of Class III Medical Devices, EU, 2019
Figure 75: Clinical Trial Approval Process, Denmark, 2020
Figure 76: Pharmaceutical Clinical Trials Count by Trial Status, Denmark, 2019-2020
Figure 77: Pharmaceutical Clinical Trials Count by Phase, Denmark, 2019-2020
Figure 78: Pharmaceutical Clinical Trials Count by Indication, Denmark, 2019-2020
Figure 79: Top Five Pharmaceutical Clinical Trials Sponsors by Count, Denmark, 2019-2020
Figure 80: Medical Device Clinical Trials Count by Trial Status, Denmark, 2019-2020
Figure 81: Medical Device Clinical Trials Count by Device Category, Denmark, 2019-2020
Figure 82: Medical Device Clinical Trials Count by Indication, Denmark, 2019-2020
Figure 83: Top Five Medical Device Clinical Trials Sponsors by Count, Denmark, 2019-2020
Figure 84: Number of Hospitals, Denmark, 2010-2018
Figure 85: Number of Diagnostic Equipment (per 100,000 population), Denmark, 2011-2019
Figure 86: Number of Hospital Beds (per 1,000 Population), Denmark, 2011-2019
Figure 87: Number of Acute Care Beds (per 1,000 Population), Denmark, 2011-2019
Figure 88: Number of Psychiatric Care Beds (per 1,000 Population), Denmark, 2011-2019
Figure 89: Life Expectancy at Birth (Years), Denmark, 2010-2018
Figure 90: Immunization Rate (% of children immunized), Denmark, 2010-2018
Figure 91: PM2.5 (µg per m3), Denmark, 2010-2017
Figure 92: CO2 Emissions (Mt CO2), Denmark, 2010-2019
Figure 93: Physicians (per 1,000 population), Denmark, 2010-2018
Figure 94: Dentists (per 1,000 population), Denmark, 2010-2018
Figure 95: Nurses (per 1,000 population), Denmark, 2010-2018
Figure 96: Pharmacists (per 1,000 population), Denmark, 2010-2018
Figure 97: Major Causes of Mortality (number of deaths), Denmark, 2017
Figure 98: Major Causes of Male Mortality (number of deaths), Denmark, 2017
Figure 99: Major Causes of Female Mortality (number of deaths), Denmark, 2017
Figure 100: Disability-Adjusted Life Years by Major Disease (‘000), Denmark, 2016
Figure 101: Healthcare Expenditure as Percentage of GDP (%), Denmark, 2010-2019
Figure 102: Public-Private Share (%), Denmark, 2010-2019
Figure 103: Healthcare Expenditure Components by Function (% of Total Health Expenditure), Denmark, 2018
Figure 104: Pharmaceutical Spending ($ per capita), Denmark, 2010-2018
Figure 105: Opportunities and Challenges